OR Royalties Announces Preliminary Q2 2025 GEO Deliveries Along with Record Quarterly Revenue & Cash Margin

(TSX:OR),(NYSE:OR), MONTRÉAL, July 07, 2025 (GLOBE NEWSWIRE) — OR Royalties Inc. (“OR Royalties” or the “Company“) (OR: TSX & NYSE) is pleased to provide an update on its second quarter 2025 preliminary deliveries, revenues and cash margin, as well as on its cash and debt positions as at June 30th, 2025. All monetary amounts included […]

OR Royalties Announces Preliminary Q2 2025 GEO Deliveries Along with Record Quarterly Revenue & Cash Margin

OR Royalties Announces Preliminary Q2 2025 GEO Deliveries Along with Record Quarterly Revenue & Cash Margin GlobeNewswire July 07, 2025 MONTRÉAL, July 07, 2025 (GLOBE NEWSWIRE) — OR Royalties Inc. (“OR Royalties” or the “Company“) (OR: TSX & NYSE) is pleased to provide an update on its second quarter 2025 preliminary deliveries, revenues and cash

Kick Back and Dive in with Dutch Bros® New Summer Drinks

Soak up all the summer fun with Dutch Bros new mocktail inspired drink trio! Here to make poolside sippin' fun for everyone, the Mudslide Mocha, Strawberry Colada and Blue Lagoon with Strawberry Fruit are now available at all 1,000+ Dutch Bros locations, while supplies last. https://mma.prnewswire.com/media/2713334/Dutch_Bros_Coffee_Summer_Social_Trio.jpg — The Mudslide Mocha takes poolside bevvys to a

Make a Splash with Summer Savings at Natural Grocers®, July 10-12, 2025

Customers can enjoy sizzling deals of up to 36% off and a chance to win a Lake Tahoe getaway, plus a fun in-store scavenger hunt on Saturday, July 12 Natural Grocers®, the largest family-operated organic and natural grocery retailer in the U.S., is turning up the summer fun with its annual Splash into Savings event,

Domino’s® Best Deal Ever is Back! Order Any Pizza with Any Toppings for $9.99

Crave-worthy secret menu pizzas you didn't know you needed are included in deal Domino's Pizza Inc. (Nasdaq: DPZ)is bringing back its “Best Deal Ever” promotion! Customers can enjoy any pizza with any toppings for $9.99 each when they order online between July 7-Aug. 3. https://mma.prnewswire.com/media/2722009/Dominos_Best_Deal_Ever_Promotion.jpg Domino's $9.99 deal includes Hand Tossed, Handmade Pan, New York

IREN June 2025 Monthly Update

(NASDAQ:IREN), SYDNEY, July 07, 2025 (GLOBE NEWSWIRE) — IREN Limited (NASDAQ: IREN) (together with its subsidiaries, “IREN” or “the Company”), today published its monthly update for June 2025. June Highlights Record monthly revenue and hardware profit3 50 EH/s mid-year target achieved AI Cloud expanded with ~2.4k Blackwell GPUs $550m convertible notes offering oversubscribed US domestic

IREN June 2025 Monthly Update

IREN June 2025 Monthly Update GlobeNewswire July 07, 2025 SYDNEY, July 07, 2025 (GLOBE NEWSWIRE) — IREN Limited (NASDAQ: IREN) (together with its subsidiaries, “IREN” or “the Company”), today published its monthly update for June 2025. June Highlights Record monthly revenue and hardware profit3 50 EH/s mid-year target achieved AI Cloud expanded with ~2.4k Blackwell

Cogent Biosciences Announces Positive Top-line Results Achieving Statistical Significance Across All Primary and Key Secondary Endpoints from the SUMMIT Trial of Bezuclastinib in Patients with Non-Advanced Systemic Mastocytosis

(NASDAQ:COGT), — Patients treated with bezuclastinib showed a superior mean change in total symptom score at 24 weeks (-24.3 points vs. -15.4 points, -8.91 point placebo-adjusted difference; p=0.0002), compared to patients treated with placebo, establishing new benchmarks for placebo-adjusted and absolute symptomatic improvement for this patient population — — Bezuclastinib demonstrated a powerful effect on

Cogent Biosciences Announces Positive Top-line Results Achieving Statistical Significance Across All Primary and Key Secondary Endpoints from the SUMMIT Trial of Bezuclastinib in Patients with Non-Advanced Systemic Mastocytosis

Cogent Biosciences Announces Positive Top-line Results Achieving Statistical Significance Across All Primary and Key Secondary Endpoints from the SUMMIT Trial of Bezuclastinib in Patients with Non-Advanced Systemic Mastocytosis GlobeNewswire July 07, 2025 — Patients treated with bezuclastinib showed a superior mean change in total symptom score at 24 weeks (-24.3 points vs. -15.4 points, -8.91

Scroll to Top